|
[Related PubMed/MEDLINE] Total Number of Papers: 20
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2023 |
Cutaneous syncytial myoepithelioma with folliculocentric growth and EWSR1 gene rearrangement: A case report. |
EWSR1 |
2 |
2022 |
CircNRIP1 Exerts Oncogenic Functions in Papillary Thyroid Carcinoma by Sponging miR-653-5p and Regulating PBX3 Expression. |
PTC, RIP |
3 |
2022 |
Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p/PBX3 axis. |
circ_0003489, miR-433-3p, MM |
4 |
2022 |
Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. |
DSCAM-AS1, ISH |
5 |
2022 |
USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling. |
ATRAP, USF1, USP14 |
6 |
2021 |
Circular RNA circ_0032962 promotes trophoblast cell progression as ceRNA to target PBX3 via sponging miR-326 in preeclampsia. |
CCK-8, circRNAs, EdU, EMT, miR-326, PE, RT-qPCR |
7 |
2021 |
HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma. |
HOXA11-AS, miR-98, NPC |
8 |
2020 |
LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis. |
ceRNA, EMT, HOXA-AS2, lncRNAs, PCa |
9 |
2020 |
PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/VEGFR2 Pathway in Papillary Thyroid Carcinoma. |
PTC |
10 |
2019 |
MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. |
GC, miR, PCR, TSA |
11 |
2019 |
miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. |
miRNAs, PC |
12 |
2017 |
Long Noncoding RNA Urothelial Carcinoma-Associated 1 Promotes the Proliferation and Metastasis of Human Lung Tumor Cells by Regulating MicroRNA-144. |
miR-144 |
13 |
2017 |
MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3. |
GBM, miR-98 |
14 |
2017 |
MiR-320 inhibits the growth of glioma cells through downregulating PBX3. |
--- |
15 |
2017 |
Molecular mechanisms of breast cancer metastasis by gene expression profile analysis. |
CAPG, DEGs, EGFR, LEF1, PLAGL1, PPI, SYK, TCF7L2, TFs, TP53INP1, TSs |
16 |
2017 |
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer. |
CC, RT-PCR |
17 |
2017 |
Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo. |
--- |
18 |
2017 |
The role of miR-320a and IL-1beta in human chondrocyte degradation. |
ACAN, ASO, MMP-13, NF-kappaB, OA, sGAG |
19 |
2016 |
MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma. |
3'UTRs, CAM, HCC, miRNAs |
20 |
2013 |
TET1 plays an essential oncogenic role in MLL-rearranged leukemia. |
HOXA9, MLL, TET1 |
|